accesso Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024
ORLANDO, Fla., Nov. 15, 2024 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the…
accesso Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024
ORLANDO, Fla., Nov. 15, 2024 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the…
accesso Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024
ORLANDO, Fla., Nov. 15, 2024 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the…
accesso Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024
ORLANDO, Fla., Nov. 15, 2024 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the…
accesso Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024
ORLANDO, Fla., Nov. 15, 2024 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the…
New Generative AI Study Highlights Adoption, Use and Opportunities in the Legal Industry
69% of legal professionals report their generative AI use will continue to…
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
HUNTSVILLE, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE…
New Generative AI Study Highlights Adoption, Use and Opportunities in the Legal Industry
69% of legal professionals report their generative AI use will continue to…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…